Oxybutynin Chloride Tablet
Product Images NDC 70518-2640

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 70518-2640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Oxybutynin Chloride 5mg 70518 2640 00

Oxybutynin Chloride 5mg 70518 2640 00
Oxybutynin Chloride is a medication that is prescription-only. It is distributed by KVK-Tech in Newtown, PA 18940 and repackaged by RemedyRepack Inc. in Indiana PA 15701. The NDC number for Oxybutynin Chloride is 70518-2640-00 and the source NDC is 10702-0201-10. The expiration date and lot number are not available. The medication should be stored at a temperature of 20-26°C (63-77°F), with excursions permitted to 15-30°C (59-86°F) [See USP]. For directions on usage of the medication, check the package insert. It is important to keep this medication out of the reach of children.*
FDA Label Image

Mm2 (Oxybutynin Chloride 5mg 70518 2640 01)

Mm2 (Oxybutynin Chloride 5mg 70518 2640 01)
Oxybutynin Chloride is a prescription medication provided by KVK-Tech, which is based in Newtown, PA 18940. It is important to keep this medication, which is identified by the NDC number, 70518-2640-01, out of the reach of children. The LOT number and expiration date are not available. The medication should be stored between 20 and 26 degrees Celsius, with excursions permitted up to 15-30 degrees Celsius, as noted by USP. For directions on how to use this medication, refer to the package insert. This medication was repackaged by RemedyRepack Inc., located in Indiana, PA.*
FDA Label Image

Oxybutynin Chloride 5mg 70518 2640 02

Oxybutynin Chloride 5mg 70518 2640 02
Oxybutynin Chloride is a prescription medication manufactured by KVK-Tech in Newtown, PA in the United States. It is only available with a prescription and can only be used as directed, meaning that it must be kept out of reach of children. The product can be stored at temperatures between 20-26°C (63-77°F) with fluctuations permitted between 15-30°C (59-86°F) as per the USP guidelines. The user should read the package insert for further instructions. It was repackaged by RemedyRepack Inc in Indiana, PA with the NDC code 70518-2640-02.*
FDA Label Image

Oxybutynin Chloride 5mg 70518 2640 03

Oxybutynin Chloride 5mg 70518 2640 03
Oxybutynin Chloride is a prescription drug manufactured by KVK-Tech located in Newtown, PA. It should be kept out of reach from children and stored between 20-26°C (63-77°F). The drug information including directions can be found in the package insert. The drug is repackaged by RemedyRepack Inc. located in Indiana, PA. The expiration date and lot number is not available.*
FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
This is a comparative study providing pharmacokinetic parameters of two forms of butynin, R-Oybutynin and S-Ouybutynin. The parameters compared include G (ng/ml) and Toa (1), as well as AUC (ng=h/mL) and UGy (ngehiml). The data shows that S-Ouybutynin has significantly higher G and UGy values than R-Oybutynin, while R-Oybutynin has a higher Toa and AUC compared to S-Ouybutynin.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
Oxybutynin Chloride is a medication that may cause adverse events in several body systems. The most common side effects associated with this drug include urinary tract infections, insomnia, nervousness, dizziness, somnolence, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention. The percentages indicate the frequency of occurrence of these side effects.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.